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Introduction: The application of portable technology to healthcare is known as mobile health 
(‘mHealth’). Instant Blood Pressure (IBP) is an mHealth app that measures blood pressure (BP) using the 
internal sensors in an iPhone, no cuff required. It was a popular app and user reviews document its use in 
management of hypertension and other BP-related conditions. It has never been independently validated. 
Methods: We enrolled adults from 5 ambulatory clinics in 2015, excluding those with an internal device, 
active arrhythmias, or who were unable to use the app. Participants guessed their BP then had two order-
randomized pairs of BP measurements taken from IBP and a sphygmomanometer (‘standard’ 
measurement). Mean absolute differences for BP were calculated comparing each IBP measurement to an 
average of the two standard measurements. We also calculated mean relative differences (IBP minus 
standard), British Hypertension Society (BHS) accuracy grading, and sensitivity and specificity for the 
detection of hypertensive measurements. Mean absolute differences and mean relative differences were 
calculated for successive same-device BP measurements. We regressed systolic and diastolic BP on IBP 
on age, sex, height, weight, and HR.  
Results: Of the 85 participants, 52% were women, mean (SD) age was 56.6 (16.3) years, BMI was 27.6 
(5.7) kg/m2; 53% self-reported hypertension. Mean absolute difference was 12.4 (10.5) mm Hg for 
systolic and 10.1 (8.1) mm Hg for diastolic. Mean relative difference was -1.2 (16.2) mm Hg for systolic 
and 7.1 (10.8) mm Hg for diastolic. IBP achieved the lowest possible BHS accuracy grades. Sensitivity 
and specificity of IBP for detection of hypertensive-range BP were 0.22 and 0.92. For BP, successive IBP 
measurements varied less than successive standard measurements. Regression analysis found that 68% 
and 85% of the variability of IBP systolic and diastolic BP results were attributable to age, sex, height, 
and weight and HR.  
Conclusions: BP measurements from an mHealth app with >148,000 copies sold were inaccurate. The 
low sensitivity for detection of hypertension means that 78% of hypertensive BPs were misclassified as 
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non-hypertensive. We suspect that the algorithm may derive its results from population curves of BP for 
entered age, sex, height, and weight.  
Advisor: Lawrence J. Appel, MD MPH 
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Mobile health (‘mHealth’) technology is broadly defined as the application of portable 
technology to health care. It has grown in popularity with the smartphone revolution. Fifty-eight percent 
of mobile users1 have downloaded at least one of the >165,000 mHealth applications (‘apps’) available on 
the Google Play and Apple iTunes app stores. While the majority of these apps are wellness-oriented 
(e.g., diet and exercise trackers),2 many mHealth apps have disease-specific functionality and are eligible 
for regulation by the Food and Drug Administration (FDA). In a 2015 guidance document, the FDA has 
opted to not enforce its regulatory capacity except in specific instances, including when an app 
“[transforms] a mobile platform into a regulated medical device…”3 Likewise, Apple guidelines state that 
apps “that provide diagnoses, treatment advice, or control hardware designed to diagnose or treat medical 
conditions that do not provide written regulatory approval upon request will be rejected.”4 Despite these 
guidelines, few of these apps have undergone regulatory review.5 
Blood pressure (BP) is a physiological measurement commonly obtained as part of a clinical 
encounter. Elevated BP is a risk factor for myriad diseases, including stroke, myocardial infarction, heart 
failure, and kidney disease.6 It is known as the ‘silent killer’ because of the asymptomatic course that, if 
left untreated, may result in morbidity or mortality. Early detection and treatment of hypertension is 
central to evidence-based preventive health care in the United States.7 Screening for hypertension is 
typically done with non-invasive BP monitors in the ambulatory setting. These class II FDA devices must 
be validated prior to approval.8 
Instant Blood Pressure (IBP; AuraLife, Newport Beach, CA) is an mHealth app that measures BP 
using just the integrated sensors of a smartphone – no cuff required ( 
Figure 1A). It was released on the Apple iTunes store on June 5, 2014 and quickly gained 
popularity (Figure 2). It ranked as a top-50 best-selling for-sale iPhone app for 156 days, which requires 
≥950 copies sold per day on average for each of these days at $4.99 per download.9 It was released on the 
Google Play store on May 9, 2014 and sold 1,000-5,000 copies.10 In addition to its commercial success, 
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IBP was celebrated as an innovative app. It won the competitive SoCal Innovation Fund award in March 
2015.11 For unclear reasons, it was removed from the Google Play store on May 9, 201512 and the iTunes 
store on July 30, 2015.13 Despite its removal, it continues to function for users that have it installed on 
their phones.  
The algorithm by which IBP produces its measurements is proprietary and undisclosed. Before 
IBP estimates BP, the app asks the user to enter their date of birth, sex, height, and weight ( 
Figure 1B). After removing any smartphone case, the user is instructed to gently place their right 
index finger across the illuminated flashlight and camera and place the microphone against the left chest ( 
Figure 1C). The user interface displays two waveforms during the measurement, the top is labeled 
“Heart” and the bottom is labeled “Pulse” ( 
Figure 1D). While it is unclear what the Heart waveform represents, an AuraLife-produced 
instructional video describes the Pulse waveform as the “pulse activity in your finger.” During the 45 
seconds of measurement, the user is coached not to create too much pressure on the index finger as it may 
cut off circulation.14 If the measurement is successful, the app will present the user with a systolic BP, 
diastolic BP, and heart rate (HR). 
IBP carries multiple disclaimers, including that it is intended for recreational use only. However, 
user reviews document use of IBP in managing multiple BP-related conditions including hypertension, 
postural orthostatic tachycardia syndrome, end-stage renal disease, and post-heart transplant care (Table 
1). IBP achieved a 4.0 star rating (out of 5 stars; higher stars indicates a more favorable user experience) 
on iTunes for its most recent version. Additionally, specific examples of recreational uses of IBP have not 
been given by the manufacturer on their website. Further, we are unaware of any recreational activity that 
involves measuring BP. Despite its removal from the iTunes store, IBP continues to function for those 
who have it installed on their smartphones. Several other ‘me too’ apps with similar functionality and no 
available validation data (e.g., Blood Pressure Pocket, Quick Blood Pressure Measure and Monitor) are 
still available for purchase.  
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As IBP provides functionality equivalent to class II FDA devices, has not been independently 
validated, and is being used in management of multiple BP-related conditions, we evaluated the accuracy 
and precision of IBP for BP measurements in adults. 
Methods 
We developed a protocol based on international sphygmomanometer validation guidelines.15 This 
protocol was approved by a Johns Hopkins University School of Medicine institutional review board. 
Clinicians at 5 ambulatory Hopkins sites (one clinic each in general internal medicine, nephrology, and 
the ProHealth clinical research unit, and two cardiology clinics) were asked to refer potentially interested 
adult patients with or without hypertension for enrollment. Individuals could be enrolled either before or 
after their scheduled appointment. Employees who expressed interest in the study were included as well. 
Adults age ≥18 years were included if they expressed interest in the trial. Individuals were 
excluded if they had an internal device like a pacemaker (per IBP recommendations), had an active 
arrhythmia (per the automated sphygmomanometer recommendations), or were otherwise unable to use 
the app (e.g., missing fingers). Per validation guidelines,15 individuals were excluded if they had change 
in successive measurements of the reference device >12 mm Hg for systolic and >8 mm Hg for diastolic. 
Individuals were also dropped if there was an error with the sphygmomanometer. Goal enrollment was 85 
individuals. 
Prior to BP measurements, participants self-reported sociodemographics, baseline health data 
(including height, weight, history of hypertension), frequency of BP monitoring, mobile technology use, 
and mHealth use. They also guessed their current BP. Participants sat quietly for 5 minutes while 
watching sex-specific manufacturer-provided instructional videos (basic and advanced IBP use for men; 
basic, advanced part 1, and advanced part 2 for women) on a portable DVD player. Following this, two 




For IBP measurements, research staff followed manufacturer guidelines using IBP version 1.2.3 
on a smartphone (iPhone 5s and 6 running iOS version 8.3, Apple Inc., Cupertino, CA). Staff entered the 
self-reported date of birth, sex, height, and weight for each participant. Study staff could attempt to obtain 
a BP result up to three times for each reading in the pair. For standard device measurements, research 
staff were trained to follow a standard protocol using calibrated, validated automated 
sphygmomanometers (Omron 907 and 907 XL).16  
Analysis 
Baseline characteristics were compared between those with full sets of IBP measurements and 
those missing ≥1 measurement. Continuous measurements were compared with two-tailed T-tests and 
proportions were compared with Chi2.  
Except where specified, all analyses compared each individual IBP measurement to an average of 
the two standard measurements (sphygmomanometer). We calculated the mean absolute differences 
between the IBP measurements and standard measurements for systolic BP and diastolic BP, calculated as 
the mean of the absolute values of the differences between BP measurements by the standard and IBP 
devices.  Mean relative differences were calculated using IBP minus standard. British Hypertension 
Society (BHS) grading17 further characterized accuracy. As BP measurements from IBP were not 
normally distributed by the Shapiro-Wilk test, Spearman ρ was used to assess correlation. Sensitivity and 
specificity for detection of hypertensive BP were calculated using systolic BP ≥140 and/or diastolic BP 
≥90 mmHg, as measured by the standard device. In addition to the analysis described above (Model A), 
sensitivity analyses for mean absolute differences of BP, mean relative differences of BP, sensitivity and 
specificity for the detection of hypertensive measurements, and Spearman ρ were calculated using three 
additional models. Model B compared the first IBP measurement to the first standard measurement. 
Model C compared the second IBP measurement to the second standard measurement. Model D 
compared an average of both IBP measurements to an average of both standard measurements.  
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Precision was assessed using mean absolute differences and mean relative differences for 
successive measurements by the same device. Mean absolute and relative difference calculations were 
repeated comparing the user’s guess of their own BP versus the standard for BP. These measures (IBP vs. 
standard and guess vs. standard) were compared using one-tailed T-tests. Mean absolute and relative 
differences were calculated for IBP versus the standard for HR. Data were visualized with scatterplots and 
Bland-Altman plots.18 
To understand the relationship of BP with data entered into the app (date of birth, sex, height, and 
weight), multiple linear regressions were performed for the first IBP and first standard systolic and 
diastolic BP measurements. The independent variables were the systolic and diastolic BP measurements 
from each device. The required data entered by the user (with age substituted for date of birth) and HR 
were dependent variables. (HR was included because of the degree of accuracy of its measurement by 
IBP). R2 was used to characterize the degree of variability in BP from the independent variables. 
Alternative regression analyses for IBP systolic and diastolic measurements were constructed using 
forward and backward stepwise selection using interaction terms, squared dependent variables, and 
splines where appropriate based upon data visualization. The final models were then compared with the 
original regression model using R2 and Akaike information criterion (AIC).19 
All analyses were performed with Stata 13.1 (StataCorp, College Station, TX).  
Results 
In August and September 2015 we prescreened 105 individuals. Written informed consent was 
obtained from 101 participants. Data from 16 individuals were discarded because of unavailable cuff 
sizes, standard device errors, and excessive variation in sequential standard device measurements (Figure 




Of 85 participants included in the study, 52% were women, mean (SD) age was 56.6 (16.3) years, 
and body mass index (BMI) was 27.6 (5.7) kg/m2; 53% self-reported hypertension, 91% of these reported 
taking antihypertensive medications (Table 2).  
Completion of Measurements 
Complete pairs of IBP measurements were obtained from 69 participants and at least one IBP 
measurement was recorded from 78 participants. Among all IBP pairs, a total of 147 measurements were 
obtained. The first IBP measurement was missing from 12 participants and the second IBP measurement 
was missing from 11 participants. The mean number of first and second attempts for IBP measurement 
were 1.6 (0.8) and 1.5 (0.8). There were a greater proportion of women and a higher mean BMI among 
those with any missing IBP measurements than those with both IBP pairs (Table 3). 
IBP BP Accuracy 
The mean absolute difference was 12.4 (10.5) mm Hg for systolic and 10.1 (8.1) mm Hg for 
diastolic. The mean relative difference (IBP minus standard) was -1.2 (16.2) mm Hg for systolic and 7.1 
(10.8) mm Hg for diastolic (Table 4, Figure 4). IBP measurements were ≤5, ≤10, and ≤15 mm Hg of the 
standard BP measurements 28%, 51%, and 68% of the time for systolic and 31%, 56%, and 81% of the 
time for diastolic, corresponding with the lowest possible BHS accuracy grade in all categories (Table 5).  
Scatterplots of IBP and standard BP demonstrate variation of measurements around the line of 
identity (solid line) and the regression line of y on x. A direct, positive relationship is evident for both 
systolic and diastolic BP (Figure 5). Spearman ρ was 0.44 (P<0.001) for systolic BP and 0.41 (P<0.001) 
for diastolic BP, indicating a moderate correlation. Hypertensive measurements that were misclassified as 
non-hypertensive are seen in the bottom right quadrant of each scatterplot. Bland-Altman plots 
demonstrate a differential pattern across the means, with IBP overestimating low BP and underestimating 
high BP for both systolic and diastolic measurements (Figure 6). 
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Sensitivity and specificity of IBP for hypertensive BP were 0.22 and 0.92 (Table 6).  These 
results indicate that of the hypertensive measurements by standard BP, 78% were misclassified as non-
hypertensive.  Of the non-hypertensive measurements, 92% were classified as non-hypertensive.  
Sensitivity Analyses 
Mean absolute difference for BP, mean relative difference for BP, sensitivity and specificity for 
detection of hypertensive BP levels, and Spearman ρ were similar in the four different analysis models 
(Table 7). 
BP Precision 
The IBP mean absolute differences for repeated measurements were 3.0 (4.2) mm Hg for systolic 
BP and 1.2 (1.5) mm Hg for diastolic BP. These measures were 4.6 (3.2) mm Hg and 2.7 (2.1) mm Hg for 
standard BP (Table 8). Visualization of the individual differences demonstrate less variability between 
IBP measurements than standard measurements for both systolic and diastolic (Figure 7).  
Guess BP Accuracy 
The mean absolute difference between the user’s guess of their BP and the standard was 9.1 (7.7) 
mm Hg and 8.3 (7.2) mm Hg for diastolic (Table 8). Scatterplots demonstrate a strong digit preference as 
well as a positive correlation and variation around the line of fit (Figure 8). Spearman’s ρ was strongly 
correlated for systolic BP (0.70; P<0.001) and moderately correlated for diastolic BP (0.53; P<0.001). In 
most analyses, guess performed better than IBP for all but mean relative difference for systolic BP. 
Bland-Altman plots do not demonstrate a strong differential pattern across the means (Figure 9). 
Sensitivity and specificity for hypertensive measurements for guessing were 0.67 and 0.90. 
IBP HR Accuracy 
The mean absolute difference for HR was 2.8 (2.4) BPM and the mean relative difference for HR 
was 1.1 (3.6) BPM. A scatterplot demonstrates minimal variation around the line of identity, which 
overlapped with the line of fit (Figure 10). A Bland-Altman plot demonstrates minimal difference across 




Regressing the systolic and diastolic results for each device onto the user profile inputs and HR 
resulted in statistical significance for weight and age for IBP systolic and IBP diastolic BP, age for 
standard systolic BP, and weight and HR for standard diastolic BP. The R2, or percentage of variance 
explained by the model, were 0.675 and 0.847 for IBP systolic and diastolic BP regressions and 0.115 and 
0.198 for standard systolic and diastolic BP regressions (Table 10). 
Based upon scatterplots relating IBP systolic and diastolic BP to age, height, weight, and HR 
(Figure 12), a spline term was generated at age 45. Models generated through forward and backward 
stepwise selections were similar to the original regression in their R2 and AIC (Table 11). 
Discussion 
In this independent validation study of the IBP app, we documented that this app performed 
poorly in measuring BP. It achieved the lowest possible BHS accuracy grade and misclassified 
approximately four-fifths (78%) of hypertensive measurements as non-hypertensive. Ambulatory patients 
in clinical settings guessed their BP with greater accuracy than IBP for three of four measures in this 
study. IBP accurately measured HR.  
IBP had a similar precision to the reference device for measurement of BP and varied little 
between subsequent BP measurements. The mean relative difference was close to zero for systolic BP and 
within 10 mm Hg for diastolic BP. A high R2 from the regression models suggest that IBP might estimate 
BP from age, sex, height, weight, and HR. These findings suggest that IBP’s BP estimates may be based 
on algorithms that incorporate data from population estimations of BP from demographic data, rather than 
direct measurements of BP alone. That it is unable to produce measurements more frequently in women 
with greater BMI suggests that breast tissue may impede the recording of the heart beat by the 
microphone. This in turn may prevent the population-derived equation from functioning as a HR may not 
be calculated. The 15-32% remaining variability for the estimated BP may be from an algorithm relating 
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audio sampling of the chest and video sampling of the fingertip. It is not clear from our data what this 
algorithm may be. 
Strengths of the study include design based on international guidelines, diverse participants, and a 
standardized protocol emphasizing best practices for sphygmomanometer use and manufacturer practices 
for IBP use. Limitations include a small distribution of diastolic BP measurements and no assessment of 
the Android IBP app.  
Our study has both clinical and public health relevance. While IBP recently became unavailable 
for unclear reasons,20 it was purchased by >148,000 users and is installed on a vast number of iPhones; 
further, several ‘me-too’ apps are still available. Hence, we remain concerned that individuals may use 
these apps to assess their BP and titrate therapy. Second, our results might have regulatory implications. 
That an app with functionality identical to FDA-regulated sphygmomanometers can top an app store’s 
sales ranks without independent validation means that processes are not in place to ensure rigorous testing 
of mHealth apps prior to release to consumers. As there are >165,000 mHealth apps available, there is an 




Table 1- Selected ratings and from iTunes for IBP version 1.2.3* 
Date of 
review Review title, user name, star rating, and review narrative 
6/7/2015 
“Emergency room nurse” by Scot21t (5 stars) 
Works for me with iPhone 6+ and with the current case I have on. I don't know the formula that 
is used to determine the blood pressure but for me is no different than an automatic machine 
taking the pressure a few times and being a few points off.  I take medicine for high blood 
pressure and works for me. 
6/5/2015 
“Life Saver!!” by Berduh (5 stars) 
I recently have and an increase in my blood pressure and now needs to be monitor.  So this app 
has been a life saver for me and now I'm able to check my pressure whenever I need to!! 
7/13/2015 
“As a Dialysis patient....” by God Iz Raw (4 stars) 
I think this is very good to have for people who suffer with high blood pressure, Dialysis 
patients, stroke patients and maybe even other patients who need to check their blood pressure 
anywhere. 
5/11/2015 
“Works great and is easy to use” by OhMia83 (5 stars) 
I love this app!! It is worth every penny. I have POTS and am taking an antihypertensive 
medication and I have to monitor by B/P to make sure I don't get hypotensive. This is so much 
easier to use than my cuff and is just as accurate. I even use my phone with my case on without 
problems. I have only had a time or two that it couldn't get a reading. This app is just the first 
step to having multiple apps that can monitor our vital signs and more! 
5/23/2015 
“I am a Heart Transplant Recipient of 02/04/2014” by Us1952 (5 stars) 
I like it... Looking forward to being able to store the test results!! Note: I am a Heart Transplant 
recipient this year 02/04/2015 Saint Luke's Mid America Transplant Institute, Kansas City, Mo. 
I take daily BP with a BP Cuff supplied by the Transplant Center. I have also been using this BP 
App. as a comparison. It is surprisingly very close to my readings. Just a couple of points off +/- 
!!! I am also a Biomedical Engineer/IT, Application Consultant for Cerner Corp. I am truly 
impressed with your BP application!!! 
7/3/2015 
“Highly recommend, surprised at accuracy” by Last Hope MN (5 stars) 
I highly recommend this app. It is quite accurate. I believe only a trained person could reach 
increased accuracy with a blood pressure cuff, on the left arm, and a stethoscope. For first aid 
situations, especially in isolated, outdoor situations, I find this app very useful, especially for a 
person going into or already in shock (continual, falling blood pressure). Severe shock can be 
fatal.  With the information, I can determine if I should activate the EPIRB - do I have a life 
threatening condition, ex. severe shock. And I can measure a person's blood pressure many 
times during a few hours. This cannot be done with a cuff (blood vessels may spasm after 
repeated measurements). Several years ago, before iPhones existed, I looked for a finger tip 
blood pressure measurement. I could only find one model, sold only in Japan, and I was unable 
to purchase it. Now, I finally have a method.  Thank to the developers. 
6/11/2015 
“Life Saver” by Cash Tracker (5 stars) 
What a great app.  Gives me the opportunity to check when I forget my meds.  Let's me know 




“Impressive “ by DrawingOne (5 stars) 
What a handy app when I want to check my BP and my cuff would be too weird to have nearby.  
As my meds are being adjusted I like to check a few times and, obviously, don't want to walk 
around with my cuff in my purse. As others have said, this app comes within a few points of my 
manual sphygmomanometer.  The usual instructions to sit quietly for 5 min (really ) before 
doing a measurement applies to the app, too. Easy to find something to do for 5 min when your 
phone is in your hand.  Terrific technology that will surprise your docs, too! 
5/23/2015 
“Great app” by Nott317 (5 stars) 
Had surgery recently and have to monitor my bp frequently. App works great and kicks out the 
same measurements as at my docs office and at my professional style home kits. My doc is 
recommending the app to other patients after tracking my progress. Pretty awesome! 
6/20/2015 
“Great” by B-den Cruz (5 stars) 
Definitely worth the download. I seem to have "white coat syndrome" so using this to take a 
measurement on my own is really helpful. 
6/29/2015 
“Excellent and practical!!!!” by Luigi5050 (5 stars) 
Easy to use, can take pressure anytime without arm or wrist gadgets and purely with the phone! 
To cap it all, this app is much more accurate and reliable than the clunky Omron machine I 
recently bought (and now returned!). 
*Downloaded from MixRank.com on January 11, 2016. The review title is presented in quotations 





Table 2 - Baseline characteristics of the 85 participants 
 Mean (SD) or % Range 
Age, y 56.6 (16.2) 18.9-81.2 
Height, cm 168.2 (10.0) 147.3-188.0 
Weight, kg 78.9 (19.2) 44.0-140.2 
BMI, kg/m2 27.6 (5.7) 17.5-45.3 
Arm circumference, cm 31.3 (5.1) 21.0-52.0 
Sociodemographics   
Male sex, % 48.2  
Race and ethnicity   
White race, % 61.2  
Black race, % 28.2  
Asian race, % 9.4  
Other race, % 1.2  
Hispanic ethnicity, % 4.8  
BP   
Systolic, mm Hg* 126.1 (17.3) 92-170 
Diastolic, mm Hg* 69.8 (11.4) 32-100 
HR, BPM 67.7 (11.8) 45-94 
Hypertensive BP measurement, %** 21.2  
Number of attempts for first IBP measurement 1.6 (0.79) 1-3 
Number of attempts for second IBP 
measurement*** 
1.5 (0.84) 1-5 
Prior diagnosis of hypertension, % 52.9  
On hypertensive medications, % of those with prior 
diagnosis of hypertension 
91.1  
Use of technology   
Owns a BP monitor, % 64.7  
Checks BP monthly or more, % 49.4  
Owns a mobile device, % 83.5  
Owns an mHealth app, % of those owning a 
mobile device 
43.7  
Non-patients, %**** 22.4  
Patients enrolled after completion of scheduled 
appointment, % 
71.2  
*Average of both standard measurements. 
**As defined by standard BP ≥140 or diastolic BP ≥90 mmHg. 
***One participant requested continued attempts until a second IBP measurement was obtained. It was 
obtained on the fifth try and was included in this analysis. 








Missing ≥1 IBP 
measurement (n=16) 
P-value* 
Age, y 55.9 (16.7) 59.6 (14.1) 0.43 
Height, cm 168.8 (10.0) 165.6 (10.3) 0.55 
Weight, kg 77.1 (19.0) 86.6 (18.9) 0.08 
BMI, kg/m2 26.9 (5.5) 30.9 (5.2) 0.01 
Arm circumference, cm 30.8 (4.5) 34.1 (7.4) 0.05 
Sociodemographics    
Male sex, % 53.6 25.0 0.04 
Race and ethnicity    
White race, % 62.3 56.3 0.65 
Black race, % 24.6 43.8 0.13 
Asian race, % 11.6 0 0.15 
Other race, % 1.4 0 0.62 
Hispanic ethnicity, % 5.9 0 0.32 
BP    
Systolic, mm Hg** 126.4 (17.6) 124.6 (17.1) 0.70 
Diastolic, mm Hg** 70.1 (11.6) 68.4 (10.4) 0.59 
Hypertensive BP measurement, %*** 20.3 25.0 0.68 
HR, BPM** 67.6 (11.4) 68.2 (13.9) 0.84 
Number of attempts for first IBP 
measurement 
1.30 (0.6) 2.6 (0.7) <0.01 
Number of attempts for second IBP 
measurement 
1.2 (0.5) 2.8 (0.9) <0.01 
Prior diagnosis of hypertension, % 55.1 43.8 0.41 
On hypertensive medications, % of 
those with prior diagnosis of 
hypertension 
92.1 85.7 0.58 
Use of technology    
Owns a BP monitor, % 63.8 68.8 0.71 
Checks BP monthly or more, % 52.2 37.5 0.29 
Owns a mobile device, % 82.6 87.5 0.64 
Owns an mHealth app, % of those 
owning a mobile device 
47.4 28.6 0.20 
Non-patients, %**** 23.2 18.8 0.20 
Patients enrolled after completion of 
scheduled appointment, % 
77.3 46.2 0.02 
*By Chi2 for proportions and T-test (two-tailed) for continuous variables. 
**Average of both standard measurements. 
***As defined by standard BP ≥140 or diastolic BP ≥90 mmHg. 




Table 4 - Mean difference of IBP minus standard BP, mm Hg (SD),n=147 IBP measurements among 85 pairs 
 Absolute Relative 
Systolic BP 12.4 (10.5) -1.2 (16.2) 
Diastolic BP 10.1 (8.1) 7.1 (10.8) 
 
Table 5 - BHS Accuracy Grade* 
Grade ≤5 mm Hg ≤10 mm Hg ≤15 mm Hg 
Cumulative percentages of readings 
A ≥60% ≥85% ≥95% 
B 50% to <60% 75% to <85% 90% to <95% 
C 40% to <50% 65% to <75% 85% to <90% 
D <40% <65% <85% 
IBP percentage in each range (grade) 
Systolic BP 28% (D) 51% (D) 68% (D) 
Diastolic BP 31% (D) 56% (D) 81% (D) 
*Percentage of IBP readings differing from the standard device by each range category.  
 
Table 6 - 2x2 table, sensitivity and specificity for hypertensive measurements* 
 Standard  
Hypertensive Non-hypertensive Total 
IBP 
Hypertensive 7 9 16 
Non-hypertensive 24 107 131 
 Total 31 116 147 
Sensitivity: 0.225 
Specificity: 0.922 
Positive predictive value: 0.438 
Negative predictive value: 0.817 




Table 7 - Sensitivity analyses* 
 Model A Model B Model C Model D 
Mean difference**     
Absolute     
Systolic BP 12.4 (10.5) 12.5 (10.5) 13.1 (10.5) 12.4 (10.3) 
Diastolic BP 10.1 (8.0) 10.3 (8.3) 10.1 (7.9) 10.3 (8.0) 
Relative     
Systolic BP -1.2 (16.2) -1.5 (16.4) -1.1 (16.8) -1.0 (16.1) 
Diastolic BP 7.1 (10.8) 7.1 (11.2) 7.1 (10.7) 7.4 (10.8) 
Detection of 
hypertensive BP 
    
Sensitivity 0.22 0.21 0.19 0.18 
Specificity 0.92 0.92 0.91 0.97 
Spearman ρ***     
Systolic 0.44 (<0.001) 0.49 (<0.001) 0.40 (<0.001) 0.43 (<0.001) 
Diastolic 0.41 (<0.001) 0.39 (<0.001) 0.42 (<0.001) 0.42 (<0.001) 
 
*Model A is the model presented in all other analyses, comparison of the individual IBP measurements to 
an average of both standard measurements. Model B is a comparison of the first IBP measurement to the 
first standard measurement. Model C is a comparison of the second IBP measurement to the second 
standard measurement. Model D is a comparison of the average of both IBP measurements to the average 
of both standard measurements. In model D, if there was only one measurement recorded for IBP, the 
lone IBP measurement was compared to an average of both standard measurements. Hypertensive 
measurements are defined as systolic BP ≥140 mm Hg and/or diastolic BP ≥90 mm Hg. 
**Presented as mm Hg (SD). The relative mean difference is IBP minus standard BP. 
***Presented as ρ (p-value)  
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Table 8 – Precision of IBP and standard for BP measurements, mean differences of subsequent measurements, mm Hg (SD)* 
 IBP Standard 
 Absolute Relative Absolute Relative 
Systolic BP 3.0 (4.2) -0.2 (5.2) 4.6 (3.2) <0.1 (5.6) 
Diastolic BP 1.2 (1.5) -0.1 (1.9) 2.7 (2.1) -0.2 (3.4) 
*Calculated as the first reading minus the second reading for each device. 
 
Table 9 - Mean difference of BP, participant’s guess minus standard, mm Hg (SD) 
 Guess vs. standard IBP vs. standard P-value* 
Absolute    
Systolic BP 9.1 (7.7) 12.4 (10.5) 0.005 
Diastolic BP 8.3 (7.2) 10.1 (8.1) 0.042 
Relative    
Systolic BP -0.3 (11.9) -1.2 (16.2) 0.672 
Diastolic BP 4.4 (10.1) 7.1 (10.8) 0.031 
*T-test, one-tailed using Model A. As the IBP measurements were obtained in pairs, they were not truly 





Table 10 - Regression analysis* 




















































-0.10 0.08 0.07*** 0.05 0.31** 28.28 0.20 
*The regression is a pairing of the first measure from each device.   







Table 11 - Forward and backward stepwise selection of regression models 
Model Variables included in the final model* R2 AIC** 
IBP systolic BP    
Original regression*** Male sex, height, weight, age, HR 0.67 486.75 
Stepwise selection type****    
Forward Height*weight, age2 0.68 479.53 
Backward Age spline ≥45*****, height*age, weight, 
weight*age, weight2 
0.71 476.55 
IBP diastolic BP    
Original regression Male sex, height, weight, age, HR 0.85 311.34 
Stepwise selection type    
Forward Height*age, height*weight 0.84 307.04 
Backward Male sex, weight*age, weight, sex*height 0.86 305.37 
*Variables available for inclusion in model building included those in Table 10, interaction terms 
between Male sex, height, weight, age, and HR, a spline at age 45, and squared terms for height, weight, 
age, and HR. 
**AIC is Akaike’s Information Criterion and can be used to compare the relative quality of regression 
models, with a lower AIC indicating a higher quality model.19  
***This is the regression analysis presented in Table 10 
****Stepwise selection used P<0.05 as the threshold for variable inclusion 
*****This spline was added based upon visualization of data with BP related to age (Figure 12). It 






Figure 1 – IBP Marketing Materials and Screenshots 


















D) 2014 IBP User Interface Screenshot 
 
  
Figure 1 images were downloaded from http://www.imedicalapps.com/2014/07/iphone-health-app-






Figure 2 - Rank on Apple iTunes Store* 
 



































Sales ranks on the iTunes app store, all for-sale apps for iPhone
IBP App Angry Birds
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• Atrial fibrillation 
(n=1) 




Discontinued because of 
sphygmomanometer errors (n=3) 
Dropped from analysis because of 
high sphygmomanometer variance 
(n=13) 
• SBP >12 mmHg (n=9) 
• DBP >8 mmHg (n=6) 
Assessed for eligibility (n=105) 
 
 















Figure 5 - Scatterplots, IBP vs. Standard for BP* 
 
*The diagonal black solid lines are lines of unity. The vertical and horizontal black solid lines are cutoffs 




Figure 6 - Bland-Altman Plots, IBP and Standard for BP* 
 




Figure 7 - Change in Successive BP Measurements* 







*The grey solid lines are the change in subsequent measures between devices. The black dashed lines are 




Figure 8 - Scatterplots, Guess vs. Standard for BP* 
 
*The diagonal black solid lines are lines of unity. The vertical and horizontal black solid lines are cutoffs 




Figure 9 - Bland-Altman Plots, Guess and Standard for BP* 
 




Figure 10  - Scatterplot, IBP vs. Standard for HR* 
 






Figure 11 - Bland-Altman Plot, IBP and Standard for HR* 
 





Figure 12 - Scatterplots of age, weight, height, and HR versus IBP for systolic and diastolic BP measurements 
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